Prenatal serum screening is a crucial step during pregnancy to estimate the risk of fetal genetic conditions. However, using race in these assessments can increase false positive results and unnecessary testing. The College of American Pathologists (CAP) recently obtained a grant to address the use of race in clinical algorithms, aiming to advance health equity for those receiving biochemical prenatal serum screening.
For the full article click here: Rethinking Race in Prenatal Risk Calculations